ROIV - Roivant Sciences Ltd.
NEXT EARNINGS:
Jun 4, 2026
EPS Est: $-0.26
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$31.25
DETAILS
HIGH:
$33.00
LOW:
$30.00
MEDIAN:
$31.00
CONSENSUS:
$31.25
UPSIDE:
10.58%
Market Cap:
20.23B
Volume:
5,569,401
Avg Volume:
7,165,053
52 Week Range:
8.73-28.29
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.23
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
GB
Employees:
908
IPO Date:
2020-12-08
EPS (TTM):
-0.24
P/E Ratio:
-42.56
Revenue (TTM):
29.05M
Total Assets:
5.44B
Total Debt:
100.17M
Cash & Equiv:
2.72B
Rev Growth (5Y):
-15.6%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-21.1%
Debt/Equity:
0.02
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-06 | $-0.24 | $-0.27 | +11.1% | $2.0M | $4.3M | -54.0% |
| 2025-11-10 | $-0.28 | $-0.32 | +12.4% | $1.6M | $5.6M | -72.0% |
| 2025-08-11 | $-0.18 | $-0.25 | +27.9% | $2.2M | $7.3M | -70.3% |
| 2025-05-29 | $-0.22 | $-0.26 | +16.5% | $7.6M | $54.1M | -86.0% |
| 2025-02-10 | $-0.13 | $-0.24 | +45.8% | $9.0M | $62.2M | -85.5% |
| 2024-11-12 | $-0.29 | $-0.25 | -17.4% | $4.5M | $45.9M | -90.3% |
| 2024-08-08 | $-0.18 | $-0.24 | +26.0% | $55.1M | $30.7M | +79.5% |
| 2024-05-30 | $-0.23 | $-0.26 | +13.0% | $28.9M | $31.0M | -6.7% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 29.05M | 32.71M | 61.28M | 55.29M | 23.80M | 67.69M |
| Net Income | (171.98M) | 4.35B | (1.01B) | (845.26M) | (809.23M) | 1.20B |
| EPS | -0.24 | 5.55 | -1.42 | -1.26 | -1.18 | 1.75 |
| Total Assets | 5.44B | 7.22B | 2.39B | 2.59B | 2.69B | 2.48B |
| Total Debt | 100.17M | 499.75M | 481.40M | 283.89M | 244.98M | 180.88M |
| Cash & Equivalents | 2.72B | 6.54B | 1.68B | 2.06B | 2.13B | 2.19B |
| Operating Cash Flow | (839.45M) | (765.27M) | (843.39M) | (677.73M) | (552.14M) | (761.83M) |
| Free Cash Flow | (844.05M) | (766.65M) | (856.08M) | (695.16M) | (557.94M) | (766.75M) |
| FCF per Share | -1.16 | -0.98 | -1.20 | -1.04 | -0.81 | -1.12 |
| Book Value | 4.69B | 5.97B | 1.16B | 1.66B | 1.90B | 2.03B |
| Cash & ST Investments | 4.89B | 6.54B | 1.68B | 2.06B | 2.13B | 2.19B |
| ROC Equity | -0.04 | 0.73 | -0.87 | -0.51 | -0.43 | 0.59 |